secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2024-03-13T23:59:59+00:00
Accession:  0001493152-24-009743
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INBS raises $10.1M via private placement of common stock and warrants
---------------------------------------------------------------------

- Gross proceeds of ~$10.1M from sale of shares, pre-funded warrants, Series H-1 and H-2 warrants at $4.55/unit.
- Offering includes 2,223,333 shares, with warrants exercisable at $4.55; H-1 term 18 months post-SEC registration, H-2 five years reduced to 20 days after 510k clearance.
- Proceeds to fund working capital, clinical trials for Intelligent Fingerprinting Drug Screening System, and market expansion.
- Ladenburg Thalmann acted as exclusive placement agent; fees include 8% cash fee plus placement agent warrants at 125% of offering price.
- Registration rights agreement: file resale registration statement by March 18, 2024, effective by April 22, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315224009743/0001493152-24-009743-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315224009743/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009743

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer